MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Biosimilars and Bioanalytical Methods
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

876 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
876 works in the cohort · of 4,299,418page 5 of 18

Labels cover 4 of 876 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 876 of 876 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Similar Names for Similar Biologics
Nicole Casadevall, Thomas Felix, Bruce Strober, David G. Warnock
2014· article· en· BioDrugs· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
14
citations
affunlabeled
Comments on the FDA draft guidance on biosimilar products
Shein‐Chung Chow, László Endrényi, Peter A. Lachenbruch
2012· article· en· Statistics in Medicine· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
14
citations
affunlabeled
Advancing nonclinical innovation and safety in pharmaceutical testing
Elizabeth Baker, Nancy A. Beck, Ellen L. Berg, Helene D. Clayton‐Jeter, P. Charukeshi Chandrasekera, J. Lowry Curley +9 more
2018· review· en· Drug Discovery Today· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
13
citations
aboutno affunlabeled
Advancing Innovations in Biosimilars
Yow‐Ming Wang, David G. Strauss
2022· editorial· en· Clinical Pharmacology & Therapeutics· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity
13
citations
affunlabeled
Recommendations on ELISpot Assay Validation by the GCC
Rafiq Islam, Jennifer Vance, Martin Poirier, Jennifer Zimmer, Ardeshir Khadang, Dave Williams +41 more
2022· article· en· Bioanalysis· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
13
citations
affunlabeled
Anti-drug Antibody Sample Testing and Reporting Harmonization
Darshana Jani, Robin Marsden, Michele Gunsior, Laura Schild Hay, Bethany Ward, Kyra J. Cowan +37 more
2022· article· en· The AAPS Journal· Immunology and Microbiology
distilled prediction:candidate · stsconsensus · none
11
citations
affunlabeled
Protein biomarker quantification by mass spectrometry
Joanna M. Hunter, Eustache Paramithiotis
2009· article· en· Expert Opinion on Medical Diagnostics· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
11
citations
affunlabeled
LDP-02 (Millenium).
J K Marshall
2001· article· en· PubMed· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
10
citations

How this was built: Screen · Findings · About